Microbiology Program

The Microbiology Program supports basic research examining the role of the oral microbiota (comprising bacteria, archaea, fungi and viruses) in dental health and disease as well as preclinical studies aimed at developing new prevention and treatment options for dental infections. Topics include examining the oral microbiota through studies in microbial ecology, physiology and genetics; polyomic technologies (genomics, metagenomics and systems biology); mechanisms of microbial virulence and pathogenesis; and classical prevention and treatment strategies for combating infectious disease.

Staff Contacts

Funding Opportunity Announcements

Title Staff Contact Opportunity Number Activity Code Expiration Date
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) PA-17-147 R43, R44
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42) PA-17-148 R41, R42
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) RFA-DE-20-002 R35
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) RFA-RM-19-012 R03
Administrative Supplements for Research on Dietary Supplements (Admin Supp) PA-18-817 P30, P40, P50
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-18-648 R13
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-18-484 R01
Change of Grantee Organization (Type 7 Parent) PA-18-590 C06, D43, D71
Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-18-591 C06, D43, D71
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional) PA-18-739 R21
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional) PA-18-738 R01
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed) PAR-18-714 R15
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) PA-18-837 R41, R42, R43
Commercializing Understudied Proteins from the IDG Project (R41/R42 Clinical Trial Not Allowed) PA-19-033 R41, R42
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed) PA-19-034 R43, R44
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed) PA-18-876 R21
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) PA-18-906 C06, D43, D71
NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) PA-19-091 R01
NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) PA-19-092 R21
NIH Administrative Supplements to Recover Losses Due to Hurricanes Harvey, Irma, and Maria Under the Bipartisan Budget Act of 2018 Non-Construction (Admin Supp Clinical Trial Optional) PA-18-936 D43, D71, DP1
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-19-134 R15
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) PAR-19-193 R01
Microbial-based Cancer Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) PAR-19-194 R21
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) PAR-19-370 R03
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) PAR-20-060 U01